Exotic and Emerging Avian Viral Diseases Research Unit Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
Avian Influenza
Asian Bird Flu
Newcastle Disease
 

Research Project: INTERVENTION STRATEGIES TO CONTROL NEWCASTLE DISEASE

Location: Exotic and Emerging Avian Viral Diseases Research Unit

Title: Experimental clinical and pathologic characterization of West African Newcastle disease viruses

Authors
item Jones, Megan -
item Cattoli, Giovanni -
item Cardenas-Garcia, Stivalis -
item Miller, Patti
item Afonso, Claudio
item Brown, Corrie -

Submitted to: American Association of Avian Pathologists
Publication Type: Abstract Only
Publication Acceptance Date: April 1, 2012
Publication Date: August 4, 2012
Citation: Jones, M.E., Cattoli, G., Cardenas-Garcia, S., Miller, P.J., Afonso, C.L., Brown, C.C. 2012. Experimental clinical and pathologic characterization of West African Newcastle disease viruses [abstract]. American Association of Avian Pathologists. p.22.

Technical Abstract: Newcastle disease is a very significant disease of commercial and backyard poultry in Africa, and has been reported in numerous African countries. Recent analysis of strains from West Africa has revealed the emergence of at least one novel genetic lineage that differs from the previously-characterized strains known to circulate in Southern Africa (1). Clinical signs and the ability to replicate and cause pathogenic damage in different tissues of three West African strains and one South African strain of Newcastle disease virus (NDV) were investigated through an experimental infection study. The West African viruses Burkina Faso/2415-580/2008, Nigeria/228-7/2006, and Niger/1377/2006, were compared to Goose/South Africa/08100426/2008, which was considered to be representative of Southern African NDV. Each strain was inoculated into a group of 4-week-old, specific pathogen free (SPF), white leghorn chickens via eyedrop, following the protocol for our standardized clinicopathologic assessment experiments. A fifth group was mock-inoculated, as a control. For each experimental group, euthanasia and complete post-mortem examination were performed at days 2, 5, and 10 post-infection, or earlier in the case of severe disease. For all strains, all virus-infected birds died, or were euthanized due to severity of clinical signs, by day 4 post-infection. Gross and histologic examination of all birds revealed severe necrosis of lymphoid tissues (spleen, thymus, Bursa of Fabricius, cecal tonsils), intestinal hemorrhage, and eyelid edema and hemorrhage. Immunohistochemical staining of lymphoid tissues revealed widespread viral antigen associated with lesions, in all cases. Results demonstrate that the three previously-uncharacterized West African strains are highly virulent, and highlight the importance of continued surveillance and virus characterization in Africa.

   

 
Project Team
Afonso, Claudio
Suarez, David
Miller, Patti
 
Publications
   Publications
 
Related National Programs
  Animal Health (103)
 
Related Projects
   NEWCASTLE DISEASE VACCINE EVALUATION
   RECOMBINANT NEWCASTLE DISEASE VACCINES: RISK FOR RECOMBINATION, REVERSION TO VIRULENCE AND SPREAD IN NON-TARGET SPECIES
   EVALUATION OF NEWCASTLE DISEASE VIRUS VACCINES AGAINST CIRCULATING VIRUSES
   PATHOGENESIS OF SELECTED NEWCASTLE DISEASE VIRUS FIELD ISOLATES AND RECOMBINANTS
   IMPROVEMENT OF NEWCASTLE DISEASE VIRUS VACCINES FOR AFRICA
   DEVELOPMENT OF CANARYPOX BASED VACCINES
   DEVELOPMENT OF CANARYPOX BASED VACCINES AGAINST MEXICAN VIRULENT NEWCASTLE DISEASE AND AVIAN INFLUENZA VIRUSES
   FOLLOW-ON: REDUCING DISEASE IN LIVESTOCK
   PATHOGENIC CHARACTERIZATION NEWCASTLE DISEASE VIRUS FIELD ISOLATES
   Pathogenic Characterization Newcastle Disease Virus Field Isolates
 
 
Last Modified: 05/25/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House